Novartis India Limited (NOVARTIND.BO)
- Previous Close
1,045.90 - Open
1,050.00 - Bid --
- Ask --
- Day's Range
1,044.00 - 1,059.65 - 52 Week Range
585.00 - 1,224.00 - Volume
11,192 - Avg. Volume
36,123 - Market Cap (intraday)
26.051B - Beta (5Y Monthly) 0.35
- PE Ratio (TTM)
27.25 - EPS (TTM)
38.72 - Earnings Date May 10, 2024
- Forward Dividend & Yield 10.00 (0.95%)
- Ex-Dividend Date Jul 20, 2023
- 1y Target Est
745.00
Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
www.novartis.in67
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: NOVARTIND.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NOVARTIND.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NOVARTIND.BO
Valuation Measures
Market Cap
26.05B
Enterprise Value
21.12B
Trailing P/E
27.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.13
Price/Book (mrq)
3.71
Enterprise Value/Revenue
6.59
Enterprise Value/EBITDA
16.13
Financial Highlights
Profitability and Income Statement
Profit Margin
28.95%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.3B
Net Income Avi to Common (ttm)
955.3M
Diluted EPS (ttm)
38.72
Balance Sheet and Cash Flow
Total Cash (mrq)
4.9B
Total Debt/Equity (mrq)
1.18%
Levered Free Cash Flow (ttm)
--
Research Analysis: NOVARTIND.BO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: NOVARTIND.BO
NOVARTIND.BO does not have Company Insights